XBiotech Inc. (XBIT)

XBiotech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	4.01	18.39	44	0
Revenue Growth (YoY)	-	-	-78.20%	-58.19%	-	-
Cost of Revenue	0	0	0.65	5.82	34.55	0
Gross Profit	0	0	3.36	12.57	9.45	0
Selling, General & Admin	4.78	4.66	6.31	9.39	18.2	7.14
Research & Development	36.44	32.85	31.54	28.27	9.53	24.09
Operating Expenses	41.22	37.51	37.85	37.66	27.73	31.23
Operating Income	-41.22	-37.51	-34.49	-25.08	-18.28	-31.23
Other Expense / Income	-10.78	-13.2	-0.9	0.38	-5.45	-749.69
Pretax Income	-30.44	-24.31	-33.59	-25.46	-12.83	718.45
Income Tax	0.31	0.24	-0.69	-8.04	-1.61	49.82
Net Income	-30.74	-24.56	-32.9	-17.41	-11.22	668.63
Shares Outstanding (Basic)	30	30	30	30	31	39
Shares Outstanding (Diluted)	30	30	30	30	31	46
Shares Change	0.02%	-0.00%	1.32%	-2.53%	-33.45%	29.37%
EPS (Basic)	-1.02	-0.81	-1.08	-0.58	-0.36	17.17
EPS (Diluted)	-1.02	-0.81	-1.08	-0.58	-0.36	14.44
Free Cash Flow	-21.73	-19.09	-15.41	65.92	-68.88	-18.47
Free Cash Flow Per Share	-0.71	-0.63	-0.51	2.19	-2.23	-0.47
Dividend Per Share	-	-	-	2.500	-	-
Gross Margin	-	-	83.77%	68.36%	21.48%	-
Operating Margin	-	-	-860.10%	-136.36%	-41.54%	-
Profit Margin	-	-	-820.45%	-94.67%	-25.50%	-
Free Cash Flow Margin	-	-	-384.26%	358.38%	-156.55%	-
Effective Tax Rate	-	-	-	-	-	6.93%
EBITDA	-28.71	-22.57	-30.97	-22.81	-10.59	720.81
EBITDA Margin	-	-	-772.42%	-124.01%	-24.07%	-
Depreciation & Amortization	1.73	1.74	2.61	2.65	2.24	2.36
EBIT	-30.44	-24.31	-33.59	-25.46	-12.83	718.45
EBIT Margin	-	-	-837.61%	-138.40%	-29.15%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).